Among the differentially expressed genes in CTL-treated Rnf31 or Vps4b knock-out PDA cells were several cytokines and chemokines, including the Cxcr3 ligands Cxcl9/10/11 (Supplementary Fig. 3f, g). This evidence concerns the gene VPS4B and Patent ductus arteriosus.